442 related articles for article (PubMed ID: 27043206)
1. Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation.
Bryant A; Atkins H; Pringle CE; Allan D; Anstee G; Bence-Bruckler I; Hamelin L; Hodgins M; Hopkins H; Huebsch L; McDiarmid S; Sabloff M; Sheppard D; Tay J; Bredeson C
JAMA Neurol; 2016 Jun; 73(6):652-8. PubMed ID: 27043206
[TBL] [Abstract][Full Text] [Related]
2. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus.
Burt RK; Traynor A; Statkute L; Barr WG; Rosa R; Schroeder J; Verda L; Krosnjar N; Quigley K; Yaung K; Villa Bs M; Takahashi M; Jovanovic B; Oyama Y
JAMA; 2006 Feb; 295(5):527-35. PubMed ID: 16449618
[TBL] [Abstract][Full Text] [Related]
3. Subcutaneous Immunoglobulin Therapy in the Chronic Management of Myasthenia Gravis: A Retrospective Cohort Study.
Bourque PR; Pringle CE; Cameron W; Cowan J; Chardon JW
PLoS One; 2016; 11(8):e0159993. PubMed ID: 27490101
[TBL] [Abstract][Full Text] [Related]
4. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A
J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn's disease.
Hommes DW; Duijvestein M; Zelinkova Z; Stokkers PC; Ley MH; Stoker J; Voermans C; van Oers MH; Kersten MJ
J Crohns Colitis; 2011 Dec; 5(6):543-9. PubMed ID: 22115372
[TBL] [Abstract][Full Text] [Related]
6. Low-Dose Medication and Long-Term Outcome in Myasthenia Gravis.
Salins S; Teter B; Kavak K; Wolfe GI; Silvestri NJ
J Clin Neuromuscul Dis; 2016 Dec; 18(2):61-66. PubMed ID: 27861217
[TBL] [Abstract][Full Text] [Related]
7. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
8. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy.
Verburg RJ; Kruize AA; van den Hoogen FH; Fibbe WE; Petersen EJ; Preijers F; Sont JK; Barge RM; Bijlsma JW; van de Putte LB; Breedveld FC; van Laar JM
Arthritis Rheum; 2001 Apr; 44(4):754-60. PubMed ID: 11315914
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
10. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.
Cassinotti A; Annaloro C; Ardizzone S; Onida F; Della Volpe A; Clerici M; Usardi P; Greco S; Maconi G; Porro GB; Deliliers GL
Gut; 2008 Feb; 57(2):211-7. PubMed ID: 17895357
[TBL] [Abstract][Full Text] [Related]
11. Autologous hematopoietic stem cell transplant for the treatment of refractory myasthenia gravis with anti-muscle specific kinase antibodies.
Beland B; Hahn C; Jamani K; Chhibber S; White C; Atkins H; Storek J
Muscle Nerve; 2023 Feb; 67(2):154-157. PubMed ID: 36527328
[TBL] [Abstract][Full Text] [Related]
12. CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan.
Ayano M; Tsukamoto H; Mitoma H; Kimoto Y; Akahoshi M; Arinobu Y; Miyamoto T; Horiuchi T; Niiro H; Nagafuji K; Harada M; Akashi K
Arthritis Res Ther; 2019 Jan; 21(1):30. PubMed ID: 30670057
[TBL] [Abstract][Full Text] [Related]
13. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease.
Musso M; Porretto F; Crescimanno A; Bondi F; Polizzi V; Scalone R
Am J Hematol; 2001 Feb; 66(2):75-9. PubMed ID: 11421302
[TBL] [Abstract][Full Text] [Related]
14. New onset of myasthenia gravis after treatment of systemic sclerosis by autologous hematopoietic stem cell transplantation: sustained autoimmunity or inadequate reset of tolerance?
Deligny C; Clave E; Sibon D; Daikeler T; Keshmandt H; Carmagnat M; Douay C; Arfi S; Clair B; Toubert A; Farge D
Hum Immunol; 2010 Apr; 71(4):363-5. PubMed ID: 20085795
[TBL] [Abstract][Full Text] [Related]
15. Autologous hematopoietic stem cell transplantation in a patient with refractory seropositive myasthenia gravis: A case report.
Sossa Melo CL; Peña AM; Salazar LA; Jiménez SI; Gómez ED; Chalela CM; Ayala-Castillo M; Peña IM
Neuromuscul Disord; 2019 Feb; 29(2):142-145. PubMed ID: 30639064
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
Witzens-Harig M; Heilmann C; Hensel M; Kornacker M; Benner A; Haas R; Fruehauf S; Ho AD
Stem Cells; 2007 Jan; 25(1):228-35. PubMed ID: 17204607
[TBL] [Abstract][Full Text] [Related]
17. Successful autologous haematopoietic stem cell transplantation for refractory myasthenia gravis - a case report.
Håkansson I; Sandstedt A; Lundin F; Askmark H; Pirskanen R; Carlson K; Piehl F; Hägglund H
Neuromuscul Disord; 2017 Jan; 27(1):90-93. PubMed ID: 27863874
[TBL] [Abstract][Full Text] [Related]
18. Robotic thymectomy in patients with myasthenia gravis: neurological and surgical outcomes.
Keijzers M; de Baets M; Hochstenbag M; Abdul-Hamid M; Zur Hausen A; van der Linden M; Kuks J; Verschuuren J; Kessels F; Dingemans AM; Maessen J
Eur J Cardiothorac Surg; 2015 Jul; 48(1):40-5. PubMed ID: 25234092
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients.
Traynor AE; Barr WG; Rosa RM; Rodriguez J; Oyama Y; Baker S; Brush M; Burt RK
Arthritis Rheum; 2002 Nov; 46(11):2917-23. PubMed ID: 12428232
[TBL] [Abstract][Full Text] [Related]
20. Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study.
Granit V; Benatar M; Kurtoglu M; Miljković MD; Chahin N; Sahagian G; Feinberg MH; Slansky A; Vu T; Jewell CM; Singer MS; Kalayoglu MV; Howard JF; Mozaffar T;
Lancet Neurol; 2023 Jul; 22(7):578-590. PubMed ID: 37353278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
